Desq Long
Sign in
SEC FORM 4
$0.00

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code A) of 45,000 shares at $0 per share.

Reporting Person Miralles Gines Diego · Officer Title President & Head of R&D · Transaction Code A

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389514 · filed 2026-09-11 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Artiva Biotherapeutics, Inc. (ARTV)." Disclosed 2026-09-11. https://desqlong.com/cards/0001193125-26-389514-1 (retrieved 2026-09-26).